Cite
HARVARD Citation
Kodali, R. et al. (2022). Timing of tofacitinib therapy is critical to improving outcomes in severe-critical COVID-19 infection: A retrospective study from a tertiary care hospital. Medicine. 101 (43), pp. e30975-. [Online].